Premenstrual disorders including premenstrual syndrome and premenstrual dysphoric disorder

Key content The spectrum of premenstrual disorders is related to hormonal changes in the menstrual cycle and are experienced by nearly 40% of women. Approximately 3-8% of women are affected by severe premenstrual syndrome, including premenstrual dysphoric disorder (PMDD); a chronic, debilitating disorder with severe emotional and physical symptoms and functional impairment. PMDD significantly affects women's quality of life; recent evidence suggests that 86% of patients have considered suicide, with 30% having attempted suicide at least once. In 2019, PMDD was added to the International Statistical Classification of Diseases and Related Health Problems, (ICD-11), which validates PMDD as a legitimate diagnosis and acknowledges growing scientific and medical understanding of this previously under recognised condition. Symptom relief can often be achieved through medical management, therefore it is important to increase awareness among healthcare professionals at all levels. Learning objectives To understand the pathophysiology, diagnosis and treatment options for premenstrual disorders, including PMDD. To know the different classifications of premenstrual disorders, including DSM-5 and World Health Organization (WHO) ICD-11 classifications of PMDD. To understand the potential benefits associated with multidisciplinary care for women with premenstrual disorders like PMDD. Ethical issues Should women with severe premenstrual syndrome be classified under mental health disorders in the ICD classification?